Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00304031 · BASELINE

Baseline characteristics

Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma · Source last updated 2020-06-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      292
    2. group Id
      BG001
      value
      411
    3. group Id
      BG002
      value
      422
    4. group Id
      BG003
      value
      1125
    units
    Participants
groups
  1. description
    Concurrent radiation therapy (RT) with concurrent temozolomide (75 mg/m2) up to 49 doses. Not randomized to either adjuvant TMZ arm.
    id
    BG000
    title
    No Adjuvant TMZ (Not Randomized )
  2. description
    Concurrent radiation therapy with concurrent temozolomide (75 mg/m2) up to 49 doses. Starting four weeks after completion of RT, 100mg/m2 adjuvant temozolomide days 1 to 5 of 28 day cycle.
    id
    BG001
    title
    Conventional Adjuvant TMZ
  3. description
    Concurrent radiation therapy (RT) with concurrent temozolomide (75 mg/m2) up to 49 doses. Starting four weeks after completion of RT, 75mg/m2 adjuvant temozolomide days 1-21 of 28 day cycle.
    id
    BG002
    title
    Dose-dense Adjuvant TMZ
  4. description
    Total of all reporting groups
    id
    BG003
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          22
          upper Limit
          87
          value
          60.5
        2. group Id
          BG001
          lower Limit
          22
          upper Limit
          84
          value
          57
        3. group Id
          BG002
          lower Limit
          21
          upper Limit
          84
          value
          58
        4. group Id
          BG003
          lower Limit
          21
          upper Limit
          87
          value
          58
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          126
        2. group Id
          BG001
          value
          172
        3. group Id
          BG002
          value
          185
        4. group Id
          BG003
          value
          483
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          166
        2. group Id
          BG001
          value
          239
        3. group Id
          BG002
          value
          237
        4. group Id
          BG003
          value
          642
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
Eligible patients who were randomized.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      292
    2. group Id
      BG001
      value
      411
    3. group Id
      BG002
      value
      422
    4. group Id
      BG003
      value
      1125
    units
    Participants
groups
  1. description
    Concurrent radiation therapy (RT) with concurrent temozolomide (75 mg/m2) up to 49 doses. Not randomized to either adjuvant TMZ arm.
    id
    BG000
    title
    No Adjuvant TMZ (Not Randomized )
  2. description
    Concurrent radiation therapy with concurrent temozolomide (75 mg/m2) up to 49 doses. Starting four weeks after completion of RT, 100mg/m2 adjuvant temozolomide days 1 to 5 of 28 day cycle.
    id
    BG001
    title
    Conventional Adjuvant TMZ
  3. description
    Concurrent radiation therapy (RT) with concurrent temozolomide (75 mg/m2) up to 49 doses. Starting four weeks after completion of RT, 75mg/m2 adjuvant temozolomide days 1-21 of 28 day cycle.
    id
    BG002
    title
    Dose-dense Adjuvant TMZ
  4. description
    Total of all reporting groups
    id
    BG003
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          22
          upper Limit
          87
          value
          60.5
        2. group Id
          BG001
          lower Limit
          22
          upper Limit
          84
          value
          57
        3. group Id
          BG002
          lower Limit
          21
          upper Limit
          84
          value
          58
        4. group Id
          BG003
          lower Limit
          21
          upper Limit
          87
          value
          58
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          126
        2. group Id
          BG001
          value
          172
        3. group Id
          BG002
          value
          185
        4. group Id
          BG003
          value
          483
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          166
        2. group Id
          BG001
          value
          239
        3. group Id
          BG002
          value
          237
        4. group Id
          BG003
          value
          642
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
Eligible patients who were randomized.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice